Speciality Chemicals Magazine

Speciality Chemicals Magazine has established itself as the top publication focused on the fine and specialty chemicals sector. Since its launch, we have committed to providing up-to-date information on business trends, market developments, and technological advancements in this vital industry.

Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#4401467

United States

#2235594

Heavy Industry and Engineering/Chemical Industry

#2742

Traffic sources

Monthly visitors

Articles

Partnership in Prussian blue

1 month ago | specchemonline.com | Andrew Warmington

Czech firm Draslovka has formed an R&D partnership with Natron Energy to develop and produce Prussian blue material required for its proprietary sodium-ion battery technologies. The agreement envisages a layered scope of co-operation across Draslovka’s areas of expertise, using its research, production and logistics capabilities on both sides of the Atlantic.
Rainbow invests in US

1 month ago | specchemonline.com | Andrew Warmington

Rainbow North America, the US subsidiary of a Chinese crop protection firm, has established a ‘partner production centre’ at Champaign, Illinois, in the heart of the Midwestern agricultural sector. This will begin with a renovation and construction activities on a 12-hectare campus and will continue with multi-phase expansion. Production operations will be in place to support the 2026 growing season.
Axplora expands ADC payloads

1 month ago | specchemonline.com | Andrew Warmington

Submitted by: Andrew Warmington CDMO Axplora has opened a GMP workshop at its Le Mans site to make payloads for ADCs. Features include three Hastelloy reactors with a production range of 30-200 L, plus space for a fourth, and a dedicated Hastelloy filter dryer for high-level containment and safety. It can produce batches of up to 1.5 kg. This is part of the France 2030 programme.
Heubach buy completed

1 month ago | specchemonline.com | Andrew Warmington

Submitted by: Andrew Warmington Following approvals from regulators and shareholders, India’s Sudarshan Chemical Industries (SCIL) has completed its acquisition of Germany-based Heubach Group, the world’s second largest pigment player, in a combined asset and share deal. Terms were not disclosed. The combined firm will have 19 sites.
Radici sells two businesses

1 month ago | specchemonline.com | Andrew Warmington

Submitted by: Andrew Warmington Italy’s RadiciGroup has signed a definitive agreement to sell its Specialty Chemicals and High Performance Polymers business areas to an affiliate of Dallas-based private equity firm Lone Star Funds. Terms were not disclosed and the deal should close in 2H, subject to customary closing conditions and regulatory approvals.
Indian owner for Senn

1 month ago | specchemonline.com | Andrew Warmington

Submitted by: Andrew Warmington CDMO Granules India has agreed to acquire Senn Chemicals, as Swiss specialist in liquid- and solid-phase peptide synthesis in a deal that should close within 1H, subject to regulatory approvals. Terms were not disclosed. The two companies have already been collaborating on two GLP-1-based APIs for anti-diabetic and anti-obesity therapeutics, a booming area in which Granules wants to expand.
IPP leases plant to Nuol

1 month ago | specchemonline.com | Andrew Warmington

International Process Plants (IPP) has leased a 151 million L/year precision fermentation plant in Little Falls, Minnesota (pictured), to Nuol Green Chemistry, which will use it to produce biochemicals including isobutanol and acetone. Nuol uses fermentation, low-pressure hydrogenation, esterification, transesterification and other technologies to develop biobased alternatives for industries such as cosmetics, pharmaceuticals, food and biofuels.
Neste Restructures Renewables Focus Amid Weak Financial Performance

2 months ago | specchemonline.com | Andrew Warmington

During its annual results presentation, Finland’s Neste announced a performance improvement programme that will, among other things, change its focus in renewables. The company said that this was the result of a “significantly changed market environment and weakened financial performance”, in addition to a comprehensive full potential analysis that started in October 2024.
Halozyme abandons Evotec bid

Nov 27, 2024 | specchemonline.com | Andrew Warmington

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it. The €11/share bid implied a fully diluted equity value of €2 billion for the German drug developer. Some analysts believe it to have been driven by financial investor Triton, which recently increased its stake in the company to 9.99%.